Acute Right Ventricular Infarction Registry

National Institute of Cardiovascular Diseases, Pakistan

Status: Enrolling

Conditions: Right Ventricular Dysfunction; Inferior Wall; Transmural Myocardial Infarction

Treatments: Other: Right Ventricular Infarct

Study type: Observational

Funder types: Other

Identifiers

NCT06424028

IRB-62/2023

Details and patient eligibility

About

This Study aims to provide an assessment of clinical presentation, management, hospital course, and prognosis of acute right ventricular infarction presenting with or without Inferior or infero-posterior wall Myocardial Infarction and the assessment of composite adverse clinical outcome after reperfusion in-hospital and post-discharge (in 30 Days Prognosis).

Full description

After fulfilling the eligibility criteria, informed consent will be obtained from all the patients regarding using data for research while maintaining anonymity.Data will be collected for various patient, system, and procedure related characteristics with the help of a predefined structured proforma consisted of demographic data, clinical presentation, history and co-morbid conditions, and angiographic and procedural characteristics. All the recruited patients will be kept under observiton during the hospital stay and a telephonic follow-up will be carried out after 30-days of discharge and occurrence of the MACE will be recorded.

Univariate and multivariable binary logistic regression analysis will be performed to determine the clinical predictors of RVI. Odds ratio (OR) along with 95% confidence interval (CI) will be reported. The statistical significance criteria will be set as p-value<0.05.

For data verification, 10% of the data will be cross-checked with the source document (Patient file).

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients of Inferior, infero-lateral and infero-posterior wall MI with and without RV infarction undergoing PPCI.
• Both male and female patients.
• Patients of age ≥ 18 years.

Exclusion criteria

• Patients who will not give consent for participation.